In Brief
Yolk-sac (YS) embryonic macrophages contribute to tissue-resident macrophages but remain difficult to study because of their stage-dependent limited availability. Takata et al. demonstrate that iPSCs can generate YS macrophage-like cells (iMacs) that differentiate into functional tissue-resident macrophagelike cells upon receiving organ-specific cues, thus providing a platform for modeling tissue-resident macrophages.
SUMMARY
Tissue macrophages arise during embryogenesis from yolk-sac (YS) progenitors that give rise to primitive YS macrophages. Until recently, it has been impossible to isolate or derive sufficient numbers of YS-derived macrophages for further study, but data now suggest that induced pluripotent stem cells (iPSCs) can be driven to undergo a process reminiscent of YS-hematopoiesis in vitro. We asked whether iPSC-derived primitive macrophages (iMacs) can terminally differentiate into specialized macrophages with the help of growth factors and organ-specific cues. Co-culturing human or murine iMacs with iPSC-derived neurons promoted differentiation into microglia-like cells in vitro. Furthermore, murine iMacs differentiated in vivo into microglia after injection into the brain and into functional alveolar macrophages after engraftment in the lung. Finally, iPSCs from a patient with familial Mediterranean fever differentiated into iMacs with pro-inflammatory characteristics, mimicking the disease phenotype. Altogether, iMacs constitute a source of tissue-resident macrophage
INTRODUCTION
Macrophages possess numerous known functions in tissue development, homeostasis, repair, and immunity (Wynn et al., 2013) . Adult macrophage populations were long assumed to be continuously replaced by monocytic precursors, but recent studies have established that multiple tissue-resident macrophage populations, including those of the brain, lung, and liver, instead derive from yolk-sac (YS) precursor cells that seed the tissues during embryonic hematopoiesis, complete their differentiation in the tissue site, and are self-maintained throughout adulthood (Hoeffel and Ginhoux, 2015; Ginhoux and Guilliams, 2016) . In order to successfully study these cells, researchers must develop methods that permit functional primary resident macrophages to be either isolated in high numbers or differentiated in vitro in a way that recapitulates their unique developmental and differentiation pathways.
Microglia are the resident macrophages of the central nervous system and are perhaps the most challenging macrophage population to study. They arise from hematopoietic stem cell (HSC)-independent erythro-myeloid progenitors (EMPs) that give rise to YS macrophages that migrate to the developing brain rudiment (Ginhoux et al., 2010; Hoeffel and Ginhoux, 2015) . Microglia are central to neuronal viability, maturation, and activity; the pruning and formation of synapses; and neuronal circuit development and maintenance of brain structures . Dysregulated microglial function has been implicated in various neurodegenerative and psychiatric disorders as well as neuroinflammatory diseases. The difficulties in isolating primary microglia have led to attempts to generate microglial-like cells from HSCs or circulating monocytes (Hinze and Stolzing, 2011; Etemad et al., 2012) . Such attempts, however, are limited by the fact that these cell populations do not share the embryonic origin of the vast majority of microglia in the steady-state brain and often overlook the key influence of tissue-specific cellular interactions on macrophage differentiation and specialization. Recent studies have outlined a path by which it might be possible to derive specialized macrophage populations in vitro by using either embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) to recreate primitive YS hematopoiesis (Sturgeon et al., 2014) . The acquisition of hematopoietic cell fate is possible by sequential exposure of ESCs to specific cytokines (Pearson et al., 2008) and subsequent Activin/Nodal signaling that selectively activates primitive hematopoiesis (Kennedy et al., 2012; Sturgeon et al., 2014; Ackermann et al., 2015) . Terminal differentiation of ESCs into macrophages in vitro has been demonstrated in both murine (Senju et al., 2009; Zhuang et al., 2012) and human cells (Karlsson et al., 2008; Choi et al., 2009) .
In this study, we asked whether iPSC-derived macrophages could be differentiated into specialized tissue macrophages and aimed to characterize their validity for in vitro and in vivo study. We designed defined iPSC differentiation protocols for the generation of homogeneous cultures of murine and human iPSC-derived primitive macrophages (iMacs) that closely resemble YS macrophages found in vivo. In co-culture with iPSC-derived neurons, iMacs differentiated and exhibited numerous features characteristic of microglia, and in vivo, murine iMacs could differentiate into functional tissue macrophage populations in both brain and lung. Finally, iMacs generated from a patient with a hereditary autoinflammatory disease (familial Mediterranean fever) exhibited key pathogenic cellular features associated with the disease. As such, iMacs present a viable tool for the study of macrophages in health and disease.
RESULTS

Murine Primitive-Macrophage-Like Cells Can Be Derived From iPSCs
We first developed a method to differentiate murine iPSCs on the basis of earlier established strategies (Gadue et al., 2006; Pearson et al., 2008) , with modifications ( Figure 1A , and see STAR Methods). IPSCs from Cx3cr1 gfp /+ reporter mice (Jung et al., 2000) were used for identifying and monitoring macrophage emergence in the iPSC cultures ( Figure S1A ) because YS macrophages and their progeny, including microglia, were fluorescently labeled (Ginhoux et al., 2010) . We defined the differentiation profile of the fluorescent iPSC population by measuring the expression levels of surface markers on alternate days of culture by using flow cytometry. Ly6C + monocytes were absent from the culture at any time point (Figure 1B) , and Ly6C expression by iMacs was minimal compared to blood or bone-marrow monocytes ( Figure 1C ), thus supporting the recapitulation of primitive-YS hematopoiesis (Hoeffel and Ginhoux, 2015) . Figure 1B) . From day 8, the relative proportion of iMacs gradually increased in the cultures and reached almost 100% of living cells by differentiation day 12 ( Figures 1B and 1F , red line), and these cells exhibited typical macrophage morphology ( Figure 1E ). A hallmark of terminally differentiated macrophages is the loss of proliferative capacity. To measure the proportion of actively proliferating cells throughout culture phases, we generated iPSCs from Fluorescent Ubiquitination-based Cell Cycle Indicator (Fucci) mice ( Figure S1B ), in which nuclei of cells in S, G2, and M phases of the cell cycle fluoresce Azami green and the nuclei of cells in G1 phase fluoresce Kusabira orange (Sakaue-Sawano et al., 2008) . We show that cells in the iPSC culture proliferated abundantly in the early terminal culture phases (Figures 1F and 1G) , as did EMPs ( Figure 1I ). However, the proportion of proliferative cells progressively decreased from differentiation day 8 when the iMacs started to emerge and then reached undetectable levels by day 16 ( Figures 1G and 1H ). These observations were confirmed by immunofluorescence microscopy ( Figure 1J ). Taken together, these findings showed that over a 16 day culture period, murine iPSCs progressively acquired macrophage marker-gene expression and morphology, as well as gradually reducing their proliferation rate, which was consistent with terminal differentiation into macrophages. The expression of CD41, CD45, CD11b, c-kit, Ly6C, MHC class II, F4/80, and CX3CR1 (green fluorescent protein, GFP/+) was monitored by flow cytometry in differentiating Cx3cr1 gfp/+ iPSC cultures (see Figure S1A ).
(C) Ly6C expression by iMacs on day 8, by adult BM monocytes, and by adult blood monocytes. ) from day 8 to day 16. Scale bars represent 50 mm. All experiments were performed three times, and data represent the means ± SD of three independent experiments. Abbreviations are as follows: EBs, embryonic bodies; EMPs, erythro-myeloid progenitors; iMac, iPSC-derived primitive macrophage; and iPSC, induced pluripotent stem cell. Figure S2A ), and their gene-expression profiles were compared to those of YS-Macs isolated on embryonic day (E) 10.5-13.5 and to brain macrophages isolated at E10.5 and E12.5 (Matcovitch-Natan et al., 2016) . RNA sequencing (RNA-seq) and hierarchical clustering analysis revealed that the transcriptional profile of iMacs was most similar to those of YS-Macs and embryonic brain macrophages, whereas BM-Macs exhibited distinct transcriptional features ( Figure 2A ). We further analyzed the 5,643 differentially expressed genes (DEGs) between iMacs and BM-Macs and identified key differences in the expression levels of genes associated, for example, with the cell cycle in iMacs versus T cell activation and/or antigen presentation (such as H2-DMa, H2-DMb1, H2-D1 and Itgb5) in BM-Macs ( Figure 2B ).
To validate these results, we checked the expression of some surface proteins, including CD48, CD93, CD9, CD38, CD81, and CD276 by flow cytometry and found that CD48 and CD93 were highly expressed on BM-Macs, whereas CD9, CD38, CD81 and CD276 were highly expressed on iMacs ( Figure 2C ). Having established the differences between the gene expression of BM-Macs and iMacs, we next focused at the differences between YS-Macs and iMacs ( Figure 2D ) and between YSMacs and BM-Macs ( Figure S2C ). Overall, there were 3,641 DEGs between BM-Macs and YS-Macs and 1,657 DEGs between iMacs and YS-Macs; 611 of these DEGs were common between the two pairs ( Figure S2D ). We also noted that DEGs between BM-Macs and YS-Macs are associated with the cell cycle (examples include Cdk9 and Cdkn1b) and antigen presentation (examples include H2DMa and H2-DMb1) ( Figure 2B ; see also Figures Figure 2SD ). Taken together, such analyses suggested that the transcriptomic signature of iMacs is much more similar to that of YS-Macs than to that of BM-Macs. One of the key functions of macrophages in vivo is to engulf particulate material. We thus compared the phagocytic capacity of Cx3cr1 gfp/+ -derived iMacs to that of BM-Macs in vitro. Despite evident differences in morphology, we observed abundant and comparable uptake of fluorescent beads and amyloid-b1-42 (Ab 1-42 )-a pathological peptide involved in Alzheimer disease (Selkoe and Hardy, 2016) -by immunofluorescence ( Figure 2E ) and flow cytometry ( Figure 2F ). As innate immune cells, macrophages constantly survey the local environment for indicators of danger or infection and initiate pro-inflammatory cytokine secretion to counter any pathogenic threats. To assess this feature, we exposed Cx3cr1 gfp/+ -derived iMacs to bacterial lipopolysaccharide (LPS), the macrophageactivating cytokine interferon (IFN)-g, or LPS plus IFN-g and measured the cytokine content of the cellular supernatants after 24 hr by Luminex cytokine and chemokine array ( Figure 2G ). The levels of the pro-inflammatory cytokine TNF-a, the chemokines CCL2, CCL3, CCL4, RANTES, and CXCL1, and the anti-inflammatory IL-10 increased significantly as compared to baseline levels after exposure to LPS or LPS plus IFN-g. LPS alone induced a marked upregulation in production of IL-6 and CXCL2, whereas IFN-g alone induced minimal cytokine production ( Figure 2G ). Taken together, these results indicate that iMacs are capable of generating an appropriate cytokine response to well-defined pathogenic stimuli in vitro.
Murine iMacs Adopt Microglia-Like Morphology in Co-culture with Neurons Embryonic macrophages complete cellular differentiation and specialization within the final resident tissue site . We therefore asked whether iMacs could similarly respond to developmental instructions from tissue-specific cell types. We sorted CD45 + CD11b + F4/80 + murine iMacs from day 12-14 cultures and seeded them onto neurons that were derived in parallel from the same batch of Cx3cr1 gfp/+ -derived iPSCs ( Figure 3A) . After 1 day of co-culture, iMac morphology was rounded or amoeboid, with a minority of the cells associating with iPSC-derived neurons. By day 3 of co-culture, the iMacs had elongated soma, and by day 7 exhibited extensive branching ( Figure 3B ). These observations are consistent with (100 ng/mL) + IFNg (10 ng/mL) for 24 hr. Unstimulated (U.S.) cells were included as controls. All experiments were performed three times, and data represent the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ****p < 0.0001 (one-way ANOVA followed by Bonferroni's multiple comparison test).
Abbreviations are as follows: BM, bone marrow; BM-Mac, bone-marrow-derived macrophage; E, embryonic; IFNg, interferon-gamma; iMac, iPSC-derived primitive macrophage; LPS, lipopolysaccharide; YS, yolk sac; and YS-Mac, yolk-sac-derived macrophage. (legend continued on next page) the morphology of steady-state ramified microglia in vivo (Figure 3C) . Low-magnification visualization of the day 7 co-cultures also indicated a heterogeneous distribution of iMacs, with population foci forming on and around the iPSC-derived neurons ( Figure S3A and see Movie S1). These morphological changes were not observed when iMacs were cultured in fresh neuron medium without neuronal cells ( Figure S3B ). High-magnification imaging of the day 7 co-cultures further suggested a direct physical interaction between iMacs and iPSC-derived neurons (Figure 3B , yellow arrows), which was later confirmed by scanning electron microscopy (SEM) ( Figure 3D ): elongated neurites were surrounded by (white arrows), physically attached to (yellow arrow), and/or capped by (red arrow) iMacs. Collectively, these observations indicate that iMacs, upon co-culture with neuronal cells, undergo a morphological and behavioral transition into microglia-like cells or ''iMicro.'' We next investigated which key factors of the neuronal coculture were responsible for the changes in iMac morphology and behavior. We first considered neuron-secreted molecules and thus collected medium from murine Cx3cr1 gfp/+ iPSCderived neuron cultures after 7 days, and compared it to nonconditioned, fresh neuron medium in terms of its effect on differentiation. We found that iMacs cultured without neurons did not undergo the morphological changes associated with the transition toward iMicros seen in the co-cultures (Figure S3C ). However, we observed that the neuron-conditioned media might have an effect on survival and differentiation. Absolute numbers of iMacs markedly decreased from day 3 to day 7 in the culture using fresh neuron differentiation medium, while to a lesser extent in the culture with the conditioned media ( Figure 3F ). Using PCR analysis ( Figure 3G ) and ELISAs ( Figure 3H ) for specific growth factors and cytokines, we showed that neuronal cultures produce CSF-1, IL-34 and CX3CL1, which could all impact iMac differentiation and survival. Collectively our findings suggest that besides the production of secreted factors, physical contact between iMacs and iPSC-derived neurons and/or extracellular matrix proteins are required for the terminal differentiation of iMacs. Monocytes and BM-Macs have been used in previous studies as precursor cells to generate microglia-like cells in vitro (Noto et al., 2010; Hinze and Stolzing, 2011) . We therefore tested whether monocytes or BM-Macs could differentiate to the same extent as iMacs ( Figure S3D -3F ). By day 14 of iMacs and iPSC-derived neurons co-culture, iMacs exhibited dramatic morphological changes that were characterized by the acquisition of finely branched dendrites. This exuberant morphology was observed to a much lesser extent in the monocytes and BM-Macs ( Figure 3E and Figure S3F for quantitative analysis). Altogether, these morphological observations suggest that murine iMacs exhibit greater potential to differentiate into microglia-like cells (iMicro), compared to monocytes or BM-Macs.
iMacs Acquire Microglia-Like Patterns of Gene and Protein Expression During Differentiation into iMicros To further characterize the terminal differentiation process from iMacs to iMicros, we assessed iMac gene-expression profiles at days 0, 3, 6 and 12 of co-culture and compared these profiles to those of BM-Macs during differentiation into cells with microglia-like morphology (BM-Micro). Principal Component Analysis (PCA) suggested that their patterns of gene expression were markedly different at day 0 of co-culture with iPSC-derived neurons, but converged as the co-culture experiment progressed ( Figure 4A ), as measured by the reduction in number of DEGs along co-culture ( Figure 4B ). This suggested that neurons imprinted common pathways to both cell types. Nevertheless, we identified 1,796 DEGs at co-culture day 12, and differences for example in genes associated with antigen presentation and T cell costimulation were identified in BM-Micros compared to iMicros ( Figure 4C ). PCA analysis of their gene expression profiles during co-culture compared to publically available embryonic (E10.5, E11.5, E12.5 and E16.5) and postnatal (P3, P6 and P9) microglia dataset (Matcovitch-Natan et al., 2016) revealed that iMicros clustered in between E12.5 microglia and P3 microglia, while BM-Micros clustered on it own ( Figure 4D ). We also investigated the common genes between Day12 iMicro DEGs and the ''top100 DEGs during development'' or the ''top100 enriched >16 fold between microglia and non-microglia CNS myeloid cells'' identified by Bennett et al. (Bennett et al., 2016) and found overlapping genes such as Upk1b or Igf1 ( Figure S4C) . We looked at genes specifically expressed by adult microglia, including P2ry12, Sall1, Mafb, Aif1 (ionized calcium binding adaptor molecule 1, Iba1), C1qa, Cx3cr1, P2ry13 and Tmem119 (Bennett et al., 2016) and tracked their temporal change in expression in iMicros versus BM-Micros during coculture at days 3, 6 and 12. The expression of all these genes was upregulated in both populations after co-culture, with the highest rate of change in expression observed over the first 3 days ( Figure 4E and S4B) . Flow cytometric analysis of the Cx3cr1 gfp/+ iMicro supported similar upregulation of the Cx3cr1 gene ( Figure 4F ). (F) Absolute numbers of GFP-positive cells in each condition on the indicated days (see Figure S3C ). (G) mRNA expression level of Csf1, Il34, and Cx3cl1 by iPSCs, iPSC-derived neuron precursor cells, and iPSC-derived neurons, as determined by real time-qPCR. (H) ELISA of CSF-1, IL-34 and CX3CL1 in the culture supernatant of fresh media or neuron conditioned media. All experiments were performed three times, and data represent the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 (one-way ANOVA followed by Bonferroni's multiple-comparison test). Abbreviations are as follows: BM-Mac, bone marrowderived macrophage; E, embryonic; iMac, iPSC-derived macrophage; iMicro, iPSC-derived microglia-like cells; miPSC, murine induced pluripotent stem cell; and P, post-natal. Figure S4A ).
(legend continued on next page)
We validated these observed changes in gene expression at the protein level ( Figure 4G ) by Cytometry by Time-of-Flight (CyTOF), which simultaneously measures the intensity of expression of up to 38 different molecules at the single cell level (Table S5 for panel details) and then processed the CyTOF data using unsupervised non-linear dimensionality reduction via t-stochastic neighbor embedding (tSNE) (Amir et al., 2013; Becher et al., 2014) . Comparison of day 0 versus day 12 expression profile revealed that iMacs and iMicros clearly segregated into two separate clusters ( Figure 4G ), indicating that iMacs differentiated in co-culture with neurons. The markers underlying such differential clustering included Iba1, CD64 and Mertk, in agreement with the acquisition of a microglial phenotype by iMacs. Indeed, similar microglia markers (CX3CR1 and TREM2) were upregulated in iMicros compared to iMacs in co-culture with mouse iPSC-derived neurons ( Figure 4H ). Altogether, these data suggested that iMacs differentiate to a certain extent into microglial-like cells, but remained closer to embryonic microglia rather than postnatal microglia.
iMicros Respond to Neuronal Injury and Exhibit Phagocytic Ability A hallmark feature of microglia in vivo is to rapidly react to inflammation or injury in the brain (Nimmerjahn et al., 2005) ; we therefore asked whether iMicros exhibited similar responses in vitro. For this purpose, we established iPSCs from Cx3cr1 gfp/+ Cx3cl1 mcherry/+ murine embryonic fibroblasts (MEFs) ( Figure S4D ) Figures 4J and 4K ). These data indicate that iMicros survey and respond to the surrounding environment similarly to bona fide microglia in the brain.
iMacs Differentiate into iMicros In Vivo
We showed that iMac can differentiate into iMicro when cultured in a conducive environment that mimics the in vivo setting. We then aimed to assess whether iMacs were able to survive and differentiate into iMicros in vivo by performing cell transfer in developing mouse brains (see STAR Methods). In depleted conditions, the iMacs integrated into the cellular population and gradually adopted a microglia-like morphology as well as expressed the microglial marker Iba1 ( Figure 5A ). Between days 0 and 7, iMacs transferred into the depleted mice gradually populated the microglial niche alongside the repopulating endogenous cells (Squarzoni et al., 2014) . From a round amoeboid-like morphology just after the injection at P0, iMacs progressively differentiate into ramified Iba1-positive microglia (Figure 5A) . iMac integration was observed with a high ratio (16 out of 18 injected pups) and was confined to a limited region of the neocortex. In control conditions, we also observed that iMacs could integrate into the neocortex with relative efficiency, potentially due to the fact that this structure is not fully populated by microglia at birth. Taken together, iMacs are able to engraft into the brain parenchyma and differentiate into iMicros, demonstrating their potentiality for therapeutic use as well as their capacity to respond to their microenvironment.
iMacs Engraft the Lung and Restore Lung Function in the Murine Pulmonary Alveolar Proteinosis (PAP) Model After demonstrating that iMacs differentiated into iMicros in vivo, we wanted to assess whether they could differentiate into other tissue-resident macrophages. We transferred 1 3 10 6 Cx3cr1 gfp/+ iMacs into the lungs of CSF-2 receptor alpha subunit knock-out (Csf2ra (E) Expression of adult microglia-specific genes on iMicros after co-culture for the indicated number of days.
(F) Flow-cytometric measurement of CX3CR1 expression using Cx3cr1 gfp/+ -derived iMicros after co-culture (see Figures S4B and S4C ). -derived iMicros after 12 days of co-culture with iPSC-derived neurons. All experiments were performed three times, and data represent the mean ± SD of three independent experiments. Abbreviations are as follows: BM-Micro, bone marrow-derived microglia; E, embryonic; iMac, iPSC-derived macrophage; iMicro, iPSC-derived microglia-like cells; miPSC, murine induced pluripotent stem cell; and P, post-natal.
mice, CSF2R-dependent alveolar macrophage development is dysregulated, which leads to an absence of mature alveolar macrophages, impaired phagocytosis, and subsequent accumulation of surfactant proteins (Guilliams et al., 2013) . Four weeks after iMac transfer, Cx3cr1 gfp/+ iMacs were detected in the lungs of Csf2ra and Csf2ra À/À mice 8 weeks after mice received iMacs, and we measured the turbidity of the fluid by optical density measurement at 600 nm ( Figure 5D ). The turbidity of the BAL fluid of the Csf2ra À/À mice that received iMacs was significantly lower than that of non-grafted Csf2ra À/À mice 8 weeks after iMac transfer (p < 0.01). We conclude that iMacs that are intra-nasally transferred to the lung can differentiate into functional alveolar macrophages-like cells in Csf2ra À/À mice, integrate into the existing population of alveolar macrophages, and functionally compensate for their inability to clear surfactant proteins. These data highlight not only the plasticity of murine iMacs but also their potential for tissue-specific functional adaptation.
Human iPSC Differentiation in Primitive-like Macrophages and Microglia
The next phase of this study extended the work performed in mice to humans by establishing an original differentiation protocol for generating human iMacs (hiMacs) under serum-free conditions ( Figure S5A ). By this method, we aimed to induce human iPSC HD33i cells (HD iPSC Consortium, 2012) to become hemangioblast-like cells, commit toward hematopoietic cells, and finally become macrophages. For this procedure, we utilized a non-EB method to regulate iPSC differentiation in defined conditions (see STAR Methods). We monitored the kinetics of hiPSC differentiation and macrophage commitment by flow cytometry ( Figure 6A ). Giemsa staining indicated that differentiated hiMacs exhibited typical macrophage morphology and morphology comparable to that of human monocyte-derived macrophages ( Figure 6B ). Furthermore, human iMacs were also able to phagocytose fluorochrome-conjugated beads and Ab 1-42 ( Figures 6C and 6D ). CyTOF ( Figure 6E ) and flow-cytometric assessment of surface-marker expression ( Figure S5B ) confirmed the macrophage-like features of hiMacs, as previously described for iMacs. When co-cultured with hiPSCderived neurons, hiMacs underwent morphological changes consistent with differentiation into microglia-like cells (hiMicros) and began to express Iba1 ( Figure 6F ). The hiMicros also demonstrated phagocytosis of latex beads and Ab 1-42 (Figure 6G ). These data indicate that, similar to their murine counterparts, hiMacs were capable of differentiating into functional microglia-like cells in vitro upon co-culture with neurons.
Functional hiMacs Model Tissue Macrophages In Vitro in Healthy and Disease-Associated States
We further extended the use of hiMacs to a model of human inflammatory diseases, namely familial Mediterranean fever (FMF).
FMF is the most common form of hereditary autoinflammatory disorders, caused by mutations in the MEFV (Mediterranean fever) gene, which encodes the inflammasome adaptor Pyrin (French FMF Consortium, 1997; The International FMF Consortium, 1997), whose dysregulation triggers the maturation of pro-inflammatory cytokines, such as IL-1b and IL-18. IPSCs were established from an FMF-affected individual carrying homozygous p.Met694Val mutations (Fidan et al., 2015) and from one of his unaffected healthy parents as a heterozygous control and were then differentiated toward hiMacs via the protocols described above. Luminex analysis revealed that after stimulation with LPS, hiMacs from the FMF-affected individual led to significantly higher production of inflammatory cytokines such as IL-1b, IL-18, TNF-a, and chemokine CCL4 than did hiMacs from the heterozygous asymptomatic parent ( Figure 7A ). Furthermore, immunofluorescent imaging indicated that ASCspeck formation, a critical component of the inflammasome (Lu et al., 2014) , was significantly upregulated in the FMF hiMacs ( Figure 7B ). Taken together, these data support the use of hiMacs as a cellular model recapitulating an inflammatory disease such as FMF.
DISCUSSION
This study describes the development of an iPSC-differentiation protocol that permits the generation of iMacs from mouse and human iPSCs that are genetically, phenotypically, and functionally similar to primitive YS-derived macrophages found in vivo.
Here, we show that our iMacs develop into microglia-like cells when co-cultured with iPSC-derived neurons or upon transfer to the brain in vivo, and they develop into functional alveolar macrophages after engraftment in the lung. Finally, iPSCs from an individual with FMF could differentiate into hiMacs with proinflammatory characteristics. We propose that this methodology gives iMacs the potential to terminally differentiate into various specialized tissue-specific macrophage populations. Using an in-house-developed defined serum-free culture protocol that permits primitive hematopoiesis from an in vitro iPSC culture, which in vivo is usually initiated in the YS (Pearson et al., 2008; Ackermann et al., 2015) , we could temporally detect the emergence of hemangioblast-like Flk-1 + cells at differentiation day 4, followed by highly proliferative EMP-like CD41 low-int CD45 low c-kit + F4/80 À cells around differentiation day 6. The final emergence of iMacs occurred around differentiation day 12, and these cells lost their proliferative capacity over time. Of note, we did not detect any Ly6C + monocytes during the derivation of iMacs. The pattern of cellular emergence that we observed is consistent with the differentiation pathway of YS-derived macrophages. Here, the cells followed a ''fast-track'' differentiation pathway to become mature macrophages; this pathway was expedited by the absence of a monocytic intermediate stage . Phenotypic analyses showed that the resultant CD11b + F4/80 + CX3CR1 + iMacs closely resembled primitive YS-Macs (Ginhoux et al., 2010) , and this was confirmed by RNA-seq analyses that indicated that these cells more closely modeled YS-Macs than BM-Macs. In terms of their cellular function, our derived iMacs exhibited phagocytic ability and, upon LPS stimulation, released pro-inflammatory cytokines, such as TNF-a, IL-1b and IL-6, characteristic of YS-Macs. Thus, we conclude that iMacs are ontogenically, phenotypically, genetically, and functionally similar to YS-Macs. Culturing iMacs with iPSC-derived neurons induced their differentiation into cells with morphology and genetic architecture comparable to microglia. Furthermore, the physical contact between the iMacs and neurons resembled the cellular interactions and ramified neuronal networks that can be observed between mature microglia and neurons in vivo (Schafer and Stevens, 2015) . The differentiation capacity and morphological changes incurred by iMacs when co-cultured with iPSC-derived neurons was higher than what could be achieved with either monocytes or BM-Macs. At the transcriptional level, although a certain level of convergence was observed between iMacs and BM-Macs, the iMac gene-expression profile was closer to that of in vivo (B) Immunocytochemical analysis and quantification of ASC-speck formation in heterozygous control and FMF patient hiMacs stimulated with 200 ng/mL LPS for 6 hr or, alternatively, pre-stimulated with 200 ng/mL LPS for 6 hr and stimulated with 10 mM Nigericin for 30 min. Scale bars represent 50 mm for low magnification and 20 mm for high magnification. All experiments were performed three times, and the data represent the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ****p < 0.0001 (Student's t test).
embryonic microglia than to that of BM-Macs. Thus, we propose that iMacs represent a more suitable cellular source of microglia than definitive hematopoiesis-derived myeloid cells. These findings raise the intriguing possibility that ontogeny, in addition to the influence of local environment (Lavin et al., 2014; Gosselin et al., 2014) , influences macrophage differentiation and functional capacity. A recent study has described the efficient generation of microglia-like cells from human iPSCs (Muffat et al., 2016) , and although the approach has similarities to the protocol we describe here, there are also many notable differences. First, although both methods of producing iMacs are comparable in terms of duration (26 days and 19 days), our protocol followed a specific approach to differentiation by utilizing a monolayer-directed differentiation technique as opposed to an EB-based differentiation technique that generates cells of all three germ layers. The overall result is that monolayer-directed differentiation produces a much higher yield of macrophages than an EB-based approach (10-20 versus 0.5-4 iMacs per starting primary stem cell, respectively). Second, we consider that our differentiation protocol more accurately reflects in vivo hemangioblast formation. Specifically, activation of the Wnt pathway is known to modulate the formation of the primitive streak (Tsakiridis et al., 2014) and hemangioblast (Cheng et al., 2008 ), yet inhibition of the Wnt pathway has been implicated in primitive hematopoiesis (Sturgeon et al., 2014) . Consequently, we exposed the iPSCs to the Wnt agonist CHIR99021 on day 0 of differentiation to activate the Wnt signaling pathway, and then on day 6 of differentiation we exposed the cells to Dkk1 to mimic the important shift that occurs in vivo in embryonic development. A third important difference between these two studies is that although we characterized the formation of iMicros when they were co-cultured with neurons, Muffat et al. predominantly characterized their iPSC-derived microglia in monoculture and only briefly assessed them under co-culture conditions. Importantly, although the soluble components of neuron-conditioned medium were sufficient for iMac survival, we found that iMacs cultured without neurons did not undergo the morphological changes associated with a transition toward iMicros, as seen in co-cultures. This finding suggests that physical contact between iMacs and neurons and/or extracellular matrix proteins might be important for iMac terminal differentiation. Accordingly, we observed by low-magnification imaging that a heterogeneous distribution of iMacs in co-culture preferably accumulated on and around iPSC-derived neurons. In addition, several studies have shown that macrophage populations exhibit distinct transcriptional signatures (Gautier et al., 2012; Lavin et al., 2014) and epigenetic marks (Gosselin et al., 2014; Lavin et al., 2014) that are imprinted by their host tissue. In conclusion, we consider it unlikely that in the absence of a neuronal environment, iMacs can differentiate into bona fide microglia.
Our study has also demonstrated the added potential of mouse and human iMacs over other resident macrophages. First, we found that iMacs engrafted in the lung of the PAP mouse model matured into alveolar macrophages and eliminated the surfactant protein that had accumulated as a result of the disease. Second, human iMacs differentiated from iPSCs that were derived from an FMF-affected individual elicited an excess inflammatory response as a result of LPS stimulation. Inflammasome activation consequent to ASC-speck formation was clearly detected in the iMacs derived from iPSCs from the FMF-affected individual. Collectively, these findings illustrate the many possibilities of mouse and human iMacs in therapeutical approaches. Our studies could help to overcome the limitations placed on research into certain rare-disease entities by the lack of an adequate supply of disease-specific primary cells, and they might facilitate the development of novel therapeutic approaches, in particular, for patients with PAP.
Finally, our approach can be extended by the development of co-culture and/or organoid systems that represent other organs, such as the liver or lung, through the use of already established iPSC-derived hepatocytes or lung epithelial cells. Studying the symbiotic interactions between macrophages and their host tissue is of importance if we want to delineate the molecular pathways that underlie the acquisition of a fully differentiated mature adult homeostatic activation state as well as to decipher the etiology of several diseases. In such contexts, the use of iPSC-derived cells will be instrumental in designing intervention strategies for inflammatory diseases as well as for several cancers in which macrophages have a central role in the clinical outcome.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to and will be fulfilled by Lead Contact Florent Ginhoux (Florent_Ginhoux@Immunol.a-star-edu.sg).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
All mice experiments and procedures were approved by the Institutional Animal Care and Use Committee of the Biological Resource Center (Agency for Science, Technology and Research, Singapore) in accordance with the guidelines of the Agri-Food and Veterinary Authority and the National Advisory Committee for Laboratory Animal Research of Singapore (ICUAC No. 151071) . The C57/BL6 mice, Cx3cr1 gfp/gfp mice and uGFP mice were obtained from Jackson Laboratory, the fluorescent ubiquitination-based cell cycle indicator (Fucci) mice were from the Riken BioResource Center, and the Csf2ra À/À mice were obtained from Dr. Christiane Ruedl, Nanyang Technological University. These mice were maintained on C57/BL6 background. All mice were bred and housed in the Singapore Immunology Network animal facility under Specific Pathogen-Free conditions. The age of mice; Figure 3C : E18.5 and P7; Figure 5A : P0, P2, P5 and P7; Figure 5B : 3 to 7 months old. The mouse cells used in in-vitro experiments were all derived from mice aged 8 to 10 weeks. All mice used in the in-vivo experiments were male, and iPSCs were generated also from male Mouse Embryonic Fibroblasts (MEFs). (Fidan et al., 2015) and Heterozygous control (Familial Mediterranean Fever Control) human iPSCs (Fidan et al., 2016) (Miltenyi, . Human Neural differentiation Medium (Neuro-Diff) consists of N2B27, less the Beta-Mercaptoethanol, and with the addition of 20 ng/mL BDNF (RnD, 248-BD), 20 ng/mL GDNF (Rnd, 212-GD), and 200 nM Ascorbic Acid.
METHODS DETAILS
Mouse iPSC Generation
Mouse iPSCs were generated using a previously published method (Takahashi and Yamanaka, 2006) . Briefly, Sox2, Klf4, Oct3/4 or c-Myc retrovirus vectors (Addgene) were introduced into Plat-E cells (Cellbiolabs, RV-101) using Lipofectamine 2000 (Invitrogen, 11668-027). The viral supernatant was then concentrated by centrifuging in a Millipore filter tube (Merck Millipore, UFC910024). The concentrated supernatant was added to the MEFs, along with 5 ug/mL of Polybrene (Merck Millipore, TR-1003-G) for transfection. The transfected cells were then passaged on to mitotically inactivated ICR MEFs-coated plates, in ES Medium: DMEM (GIBCO, 11960-044), 15% FBS (Serana, S-FBS-SA-015), 2 mM Glutamic Acid, 55 um Beta-Mercaptoethanol, 50 ng/mL Gentamicin (Merck Millipore, 345815) and 1 3 10 3 units/mL of mouse LIF. The ES Medium was changed daily, and then switched to KSR Medium supplemented with LIF from day 8 onward. After 2 weeks, iPSC colonies were manually picked up and plated on to mitotically inactivated MEFs-coated plates, and pluripotency was confirmed via qPCR.
Mouse iPSC-derived Macrophage (iMac) Generation
Our differentiation protocol consists of four phases. In the first phase (days 0-2), primitive streak-like mesodermal progenitors were generated by incubation of iPSCs with bone morphogenetic protein 4 (BMP-4) and basic fibroblast growth factor (FGF-2) (Pearson et al., 2008) . The Mouse iPSCs were first separated from the inactivated MEFs feeder layer by overnight culture on gelatin-coated plates. The iPSC were then seeded on to a bacterial grade 10 cm dish (4.0 3 10 6 cells per dish) in SF-Diff medium supplemented with 5 ng/mL of FGF-2 (RnD, 233-FB), 5 ng/mL of BMP-4 (RnD, 314-BP), 0.5 mM Ascorbic Acid and 0.45 mM MTG (Differentiation Day 0). During the second phase (days 2-4), hemangioblast-like cells formed and were committed to hematopoietic fate as a result of incubation with BMP-4, FGF-2, Activin A and Vascular Endothelial Growth Factor (VEGF). The resulting Embryonic Bodies (EBs) from the first phase were collected after 48 hr, broken apart by Tryple (GIBCO, 12605-010) digestion for 5 min, and then centrifuged for 5mins at 300 g. The cells were seeded on to another bacterial grade 10cm dish (4.0 3 10 6 cells/dish), in SF-Diff supplemented with 5 ng/mL FGF-2, 5 ng/mL VEGF (RnD, 293-VE), 2 ng/mL Activin A (RnD, 338-AC), 2 ng/mL BMP-4), 0.5 mM Ascorbic Acid and 0.45 mM MTG (Differentiation Day 2). After another 48 hr, the Flk-1-positive hemangioblast-like cells were collected from the embryonic bodies (EBs) by magnetic-activated cell sorting (MACS), using Flk-1 MACS separation kit (Miltenyi, ).
In the third phase (days 4-6), cells were differentiated further by cellular exposure to VEGF to drive hematopoietic commitment, and colony stimulating factor 1 (CSF-1) to support the emergence of primitive macrophages. The Flk-1+ cells were seeded on to ultralow attachment 6 well plates (Corning, CLS3471) (1.0 3 10 6 cells/well) in SF-Diff Medium supplemented with 5 ng/mL VEGF, 100 ng/mL CSF-1 (RnD, 216-MC), 0.5 mM Ascorbic Acid and 0.45 mM MTG (Differentiation Day 4) to further drive the hematopoietic commitment, as well as to support the emergency of primitive macrophages.
In the final, fourth phase (day 6 onward), the cells were further committed to the macrophage lineage and expanded in number by continuous stimulation with interleukin (IL)-3, stem cell factor (SCF) and CSF-1 (Clanchy and Hamilton, 2013) . The EBs from the third phase were collected as above, and reseeded on to normal 6 well plates (1.0 3 10 6 cells/well) in Stempro Medium, supplemented with 50 ng/mL CSF-1, 10 ng/mL IL-3 (RnD, 203-IL) and 100 ng/mL SCF (RnD, 255-SC), for another 5 to 7 days before use (Differentiation Day 6/Terminal Differentiation). Human iPSC-derived Macrophage (hiMac) Generation In order to generate hiMacs, in the first step (days 0-6), we used a modified protocol (Kennedy et al., 2007) to recreate mesoderm specification and induce human hemangioblast-like cell formation, with the addition of CHIR99021 (Kanke et al., 2014) . Human iPSC colonies were specified to the mesoderm by incubation wwith BMP-4 and VEGF, and their differentiation boosted by incubation with CHIR99021 (Kanke et al., 2014) during the first 2 days of differentiation. Hemangioblast formation was induced by adding FGF-2 instead of the CHIR99021 (days 2-4) and then maintained with VEGF and FGF-2 (days 4-6). In the next step (days 6-10), we then induced the commitment of the hemangioblast toward hematopoietic cells using a modified version of the protocol by Grigoriadis (Grigoriadis et al., 2010) , with the notable addition of DKK1, a Wnt antagonist to inhibit Wnt signaling for the promotion of primitive hematopoiesis (Sturgeon et al., 2014; Ackermann et al., 2015) . Hematopoietic cells were matured by continued incubation with SCF, FGF-2, IL-3 and IL-6, which was added to promote hematopoietic maturation and CSF-1R expression (Chomarat et al., 2000) (days 12-16). From day 16, terminal differentiation to hiMac was initiated by exposure to CSF-1. In more details, human iPSCs (HD33i) were cultured to 75% confluency, then digested with 1 mg/mL collagenase (GIBCO, 17104-019) for 20mins. The cells were collected by mechanical scrapping, generating aggregates between 50 to 200um, centrifuged at 300 g, resuspended in mTesr1 and passaged at a ratio of 1:25 (roughly 1.0 3 10 5 cells) on to a Matrigel-coated 6 well plate. Starting from the next day, with a full media change every other day, the cells were cultured for the next 16 days in Stempro Medium, supplemented with the following cytokines during the differentiation process: Differentiation Day 0 (5 ng/mL BMP4, 50 ng/mL VEGF, and 2 uM CHIR99021), Differentiation Day 2 (5 ng/mL BMP4, 50 ng/mL VEGF, and 20 ng/mL FGF2), Differentiation Day 4 (15 ng/mL VEGF and 5 ng/mL FGF2), Differentiation Day 6 to 10 (10 ng/mL VEGF, 10 ng/mL FGF2, 50 ng/mL SCF, 30 ng/mL DKK-1 (RnD, 5439-DK), 10 ng/mL IL-6 (RnD, 206-IL), and 20 ng/mL IL-3), Differentiation Day 12 and 14 (10 ng/mL FGF2, 50 ng/mL SCF, 10 ng/mL IL-6, and 20 ng/mL IL-3). From Differentiation Day 16, the cells were switched to SF-Diff supplemented with 50ng/mL CSF-1, and full medium change was done every 3 days up to Differentiation Day 25, when the floating cells were used for experiments. The cells were also cultured in a hypoxia incubator for the first 8 days, set to 5% CO 2 and 5% O 2 , and were cultured in a normal incubator after Differentiation Day 8. Floating cells typically appeared around Differentiation Day 7, and were collected and re-plated on to the basement cells during medium changes.
Mouse iPSC-derived Neuron Generation A differentiation method described previously (Ying et al., 2003) was used to induce the neurons from miPSC. Briefly, the Mouse iPSCs were plated on to Gelatin-coated 6 well plates (5 3 10 5 cells per well) in N2B27 medium for 5 days, with half medium changed daily. After the 5 th day, the cells were harvested via Tryple digestion, then re-seeded on to Polyornithine (Sigma-Aldrich, P4957) and Laminin (GIBCO, 23017-015)-coated 6 well plates (2.0 3 10 5 cells per well) in N2B27 medium for another 7 days before use.
Human iPSC-derived Neuron Generation
For the differentiation of human iPSCs toward neurons, a previously described method (Brennand et al., 2011; Li et al., 2011 ) was adopted with some modifications. Briefly, 80% confluent human iPSCs were dissociated to single cells with Accutase (StemCell Technologies, Inc., 07920). Cells were then re-suspended in NPC medium supplemented with 0.1 uM Compound E (Merck Millipore, 565790) and plated on to a Matrigel-coated 6 well plate (5.0 3 10 5 cells per well), with daily medium changes for 7 days. The cells were then passaged at a 1:3 ratio, then cultured in NPC medium supplemented with 10 uM ROCK inhibitor (Merck Millipore, Y-27632) for the initial passage. The NPCs were then conditioned and expanded in NPC medium supplemented with 20 ng/mL epidermal growth factor (RnD, 236-ED) and 20 ng/mL FGF2. For the terminal differentiation to neurons, confluent NPCs were dissociated to single cells with Accutase, resuspended in Neuro-Diff then seeded on to Polyornithine and Laminin-coated 6 well plates (1.5 3 10 5 cells per well), with half medium changed every 3 days.
Co-culturing of Human/Mouse iMacs with Neurons iMacs and neurons produced from the same batch of Mouse iPSCs were used for mouse cell co-culture experiments. The mouse iMacs were sorted for CD45 + CD11b + F4/80 + using a BD FACSAria II flow cytometer, before being added to differentiating neurons between days 12-14 of differentiation. BM-Macs and monocytes were prepared as described above, before being added to the neurons on day 7 of neuronal differentiation. For the human cell Co-culture experiments, human iMacs and neurons were likewise produced from the same batch of Human iPSCs. In this case, the hiMacs were sorted for CD45 + CD11b + CD163 + CD14 + CX3CR1 + , and added to differentiating neurons on day 14 of neuronal differentiation.
Immunocytochemistry
The cells were fixed in 4% PFA for 10mins, then stained as per standard procedures. The primary antibodies used were chicken anti-GFP (Abcam, ab13970; 1:1000), mouse anti-Beta III Tubulin (Abcam, ab78078; 1:2000) , rabbit anti-Iba1 (Wako, 019-19741; 1:1000), rabbit anti-Monomeric Azami-Green 1 (MBL, PM052M; 1:200), mouse anti-Monomeric Kusabira-Orange 2 (MBL, M168-3M; 1:200) and rabbit anti-ASC (Adipogen, AG-25B-0006-C100; 1:400). The images were captured using a confocal laser scanning microscope (Olympus, Japan) and analyzed with ImageJ software (NIH) or Imaris Software (BITPLANE). For the ASC-Speck analysis, the cells were stimulated with Lipopolysaccharide (Sigma-Aldrich, L2630) and Nigericin (Invitrogen, tlrl-nig) for the indicated time before fixation.
Cytospin
The cells were spun onto glass slides using Cytospin 4 (Thermofisher, United States), and fixed in methanol overnight. Staining was performed using Giemsa solution (Sigma-Aldrich, 32884) following 0.3% Wright solution (Sigma-Aldrich, 32857).
Flow Cytometry
Standard staining procedures were used to prepare the cells for flow cytometry analysis. The antibodies used are provided in Table  S5 . Data was acquired by LSRII (BD Bioscience) and analyzed by Flow Jo (Tree Star, Inc.). For cell sorting, cells were sorted using FACS Aria II (BD Bioscience) or FACS Aria III (BD Bioscience).
Mass Spectrometry
The cells were prepared, stained and recorded in the same method as previously described (Becher et al., 2014) . The antibodies used can be found in Table S5 . Analysis of the results was done using CytofKit (Chen et al., 2016) .
Phagocytosis Assay
FluoresbriteÔ Polychromatic Red 1.0 um Latex beads (Polyscience Inc., 18660) or TAMARA labeled amyloid b (Ab) (1-42) (Anaspec, AS-64519) were added to the culture medium. After 24 hr, the cells were analyzed by laser confocal microscopy or flow cytometry as above.
Scanning Electron Microscopy
The cells were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer for 1 hr (pH 7.4) at room temperature, treated post-fixation with 1% osmium tetroxide (Ted Pella Inc) at room temperature for 1 hr, and then dehydrated through a graded ethanol series from 25% to 100% and critical point dried using a CPD 030 critical point dryer (Bal-Tec AG, Liechtenstein). The surface on which the cells were grown and the adhesive surface was coated with 5 nm of gold by sputter coating using a SCD005 high-vacuum sputter coater (BalTec AG). The coated samples were examined with a field emission JSM-6701F Scanning Electron Microscope (JEOL Ltd., United States) at an acceleration voltage of 8 kV using the in-lens secondary electron detector.
Laser Ablation
Mouse iPSC-derived neurons were stained with 5ul/mL DiI (Molecular Probes, V22889) and mouse iMacs were added on top of the neuron culture. After co-culture day 14, a two-photon microscope (Lavision, Germany) with water-dipping objectives (20 3 , NA = 1.0) for image acquisition. Injury was induced by exposing a 75 mm 2 area to a 850 nm wavelength laser (Coherent Chameleon Ultra II One Box Ti:sapphire laser, 3.4 W, pulse length of 140 fs, 80 MHz repetition rate) for 5-10 s. To document the macrophage response toward laser injury, images (stack size 80 mm, step size of 2 mm) were consecutively acquired at 1 min intervals for 1 hr, using an excitation wavelength of 950 nm. The DiI and GFP signals were collected using the 565/24 and 500/24 filters respectively.
iMac adoptive transfer in postnatal mouse brain Pregnant wild-type C57/BL6 mice were injected (i.p.) twice with anti-colony stimulating factor 1 receptor (CSF-1R) antibody (clone AFS98, homemade) at E6.5 and E7.5 to deplete endogenous macrophages including microglia in embryos in order to give the transferred iMacs a selective advantage for colonization and engraftment. Newborn control and depleted mice (P0) were then injected with Cx3cr1 gfp/+ mouse iMacs (2.5 3 10 4 cells) into the left lateral ventricle. For immunohistochemistry, animals were perfused with 4%
PFA, dissected and post-fixed overnight at 4 C and directly cut. Immunohistochemistry was performed on free-floating 60 (P7) to 80 (P0 to P5) mm-thick vibratome. Slices were incubated 1h at room temperature in 0,1% Triton X-100, 10% Fetal Bovine Serum in PBS, and then incubated with primary antibodies overnight at 4 C in the same blocking solution: chicken anti-GFP (1/1000; Aves), rabbit anti-Iba1 (1/500; Wako Pure Chemical Industries). Sections were rinses in blocking solution and incubated overnight at 4 C with secondary antibodies (1/400 in PBS, Jackson ImmunoResearch): Alexa Fluor 488-conjugated donkey anti-chicken, Cy3-conjugated donkey anti-rabbit. Hoechst (1/1000; Sigma) was used for fluorescent nuclear counterstaining. The images were acquired using a confocal laser-scanning microscope (Leica TCS SP5) and images analyses were performed with ImageJ software.
